Montserrat Plana

Grupo de investigación

Sida e infección por VIH Accredited researcher (R3A)

mplana@recerca.clinic.cat 0000-0002-0767-4329

Publicaciones destacadas

Use of RT-defective HIV virions: new tool to evaluate specific response in infected individuals

Autores:
Guardo, Alberto Crespo; Alvarez-Fernandez, Carmen; Arberas, Hodei; Garcia-Perez, Javier; Garcia, Felipe;

(...)

Gatell, Jose Maria; Mothe, Beatriz; Alcami, Jose; Sanchez-Palomino, Sonsoles; Plana, Montserrat.

Referencia: Plos One 2013.
In vitro effects of the CCR5 inhibitor maraviroc on human T cell function

Autores:
Arberas, H; Guardo, A C; Bargallo, M E; Maleno, M J; Calvo, M;

Blanco, J L; Garcia, F; Gatell, J M; Plana, M.

Referencia: Journal Of Antimicrobial Chemotherapy 2013.
A dendritic cell-based vaccine elicits T cell responses associated with control 1 replication

Autores:
Garcia, Felipe; Climent, Nuria; Guardo, Alberto C; Gil, Cristina; Leon, Agathe;

(...)

Dalmau, Judit; Clotet, Bonaventura; Gatell, Josep M; Plana, Montserrat; Gallart, Teresa.

Referencia: Science Translational Medicine 2013.
Therapeutic vaccines against HIV infection

Autores:
Garcia, Felipe; Leon, Agathe; Gatell, Josep M; Plana, Montserrat; Gallart, Teresa;

Referencia: Human Vaccines & Immunotherapeutics 2012.
Phenotypic and functional characteristics of HIV-specific CD8 T cells and gag sequence variability after autologous dendritic cells based therapeutic vaccine

Autores:
Lopez, Anna; Van Der Lubbe, Nils; Sanchez-Palomino, Sonsoles; Arnedo, Mireia; Nomdedeu, Meritxell;

(...)

Maleno, Maria J; Garcia, Felipe; Gallart, Teresa; Gatell, Jose M; Plana, Montserrat.

Referencia: Vaccine 2009.
Short Communication: Natural killer cells and expression of KIR receptors in chronic HIV type 1-infected patients after different strategies of structured therapy interruption

Autores:
Peña Sanchez de Rivera, Jose Maria; Mestre, Gabriel; Garcia, Felipe; Martinez, Esteban; Milinkovic, Ana;

(...)

Argelich, Roger; Lozano, Jose Manuel; Pena, Jose; Gatell, Jose M; Plana, Montserrat.

Referencia: Aids Research And Human Retroviruses 2008.
Redistribution of FOXP3-Positive regulatory T cells from lymphoid tissues to peripheral blood in HIV-Infected patients

Autores:
Mozos, Ana; Garrido, Marta; Carreras, Doaquim; Carreras, Joaquim; Plana, Montse;

Diaz, Alba; Alos, Llucia; Campo, Elias; Garcia, Felipe; Martinez, Antonio.

Referencia: Jaids-Journal Of Acquired Immune Deficiency Syndromes 2007.
Relevance of HIV-1-specific CD4+ helper T-cell responses during structured treatment interruptions in patients with CD4+ T-cell nadir above 400/mm3

Autores:
Plana, Montserrat; Garcia, Felipe; Oxenius, Annette; Ortiz, Gabriel M; Lopez, Anna;

(...)

Hirschel, Bernard; Phillips, Rodney E; Nixon, Douglas F; Gallart, Teresa; Gatell, Jose M.

Referencia: Jaids-Journal Of Acquired Immune Deficiency Syndromes 2004.
Plasma stromal cell-derived factor (SDF)-1 levels, SDF1-3''A genotype, and expression of CXCR4 on T lymphocytes: their impact on resistance to human immunodeficiency virus type 1 infection and its progression

Autores:
Soriano, A; Martínez, C; García, F; Plana, M; Palou, E;

(...)

Lorenzo, JI; Alcamí, J; del Romero, J; Miró, JM; Gallart, T.

Referencia: Journal Of Infectious Diseases 2002.
Immunologic reconstitution after 1 year of highly active antiretroviral therapy, with or without protease inhibitors

Autores:
Plana, M; Martinez, C; Martinez, Catalina; Garcia, F; Garcia, Felipe;

(...)

Miro, Jose M; Pumarola, T; Gallart, T; Gallart, Teresa; Gatell, JM.

Referencia: Jaids-Journal Of Acquired Immune Deficiency Syndromes 2002.

Proyectos destacados

Red Temática de Investigación Cooperativa en Salud - SIDA (RIS)

Investigador/a principal: Felipe García

Financiador: Instituto de Salud Carlos III

Código: RD16/0025/0002

Duración: 01/01/2017 - 31/12/2022
Evaluating a Combination of Immune-based Therapies to Achieve a Functional Cure of HIV Infection (HIVACAR)

Investigador/a principal: Felipe García

Financiador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) (Sede o evento); European Comission. CE_H2020-SC1_16abr1s

Código: CE_H2020-SC1_16abr1s

Duración: 02/01/2017 - 31/12/2021
FluNanoAir Design of Human Influenza vaccines using multifunctional micelles harnessing innate immunity

Investigador/a principal: Montserrat Plana IP from Partner 2 (FCRB / IDIBAPS)

Financiador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); EuroNanoMed II JTC 2016

Duración: 01/01/2017 - 31/12/2019
European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates

Investigador/a principal: Felipe Garcia Alcaide, Giuseppe Pantaleo Co-IP

Financiador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) incluyendo 39 partners (Sede o evento); European Comunity's (H2020) Grant agreement n° 681032 ; European Comission

Código: CE_H2020-PHCRTD-15

Duración: 02/01/2016 - 31/12/2020
DESARROLLO DE UNA VACUNA TERAPÉUTICA FRENTE AL VIH BASADA EN UNA NUEVA FORMULACIÓN DE mRNA CON NANOPARTÍCULAS

Financiador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento); FIS (Fondo de investigación Sanitaria; ISCIII) FIS PI15/00480

Duración: 01/01/2016 - 01/01/2018

Montserrat Plana

Grupo de investigación

Publicaciones destacadas

Proyectos destacados

Red Temática de Investigación Cooperativa en Salud - SIDA (RIS)

Evaluating a Combination of Immune-based Therapies to Achieve a Functional Cure of HIV Infection (HIVACAR)

FluNanoAir Design of Human Influenza vaccines using multifunctional micelles harnessing innate immunity

European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates

DESARROLLO DE UNA VACUNA TERAPÉUTICA FRENTE AL VIH BASADA EN UNA NUEVA FORMULACIÓN DE mRNA CON NANOPARTÍCULAS

Suscríbete a la Newsletter del Clínic